Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...

Sana Biotechnology, Inc. (NASDAQ:SANA) ranks among the best CRISPR stocks to buy. On June 24, Citizens JMP reaffirmed its $5 ...

SAN DIEGO, June 18, 2025--DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th ...

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...

DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85 th Scientific Sessions of ...

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 Provided by Business Wire Jun 18, 2025, 5:30:00 AM ...

1 Novo Nordisk data on file. Attachment PR250610-ADA-Curtain-Raiser MENAFN10062025004107003653ID1109655815 ...

Presented at ADA 2025. 3 Crawford, MA, et al. “Real-World Dexcom CGM Use in T2D NIT: Reduced Diabetes Distress and Improved Self-Care Behaviors.” Presented at ADA 2025.

News AP Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 Business Wire Jun 18, 2025 1 of 2 ...